Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA)

Cerba Research announces membership of HKBMIA to act as an advisor on speciality testing and routine clinical trials testing to advance research and health while supporting Asia pacific healthcare companies develop new therapeutics.  

HKBMIA actively introduces bio-pharmaceutical innovation technology projects from overseas and assist in various aspects, including fundraising, R&D technology, patent protection, regulations, valuation, clinical trial design and planning, contract development manufacture, project commercialization to enter Mainland China and Asia markets.  

Through collaboration with members of HKBMIA, Cerba Research aims to deepen the understanding on the role of speciality testing with a multi-specialist laboratory provider to support the research and development of new therapeutics.  

“The ambition of HKBMIA is to promote communication, exchange and cooperation amongst the biomedical innovation technology industry, research institutions, investment industry and government organizations. The understanding of Asia pacific companies regarding contract research organisations and central and speciality lab testing is limited, and the assistance that Cerba Research can provide to our bio-tech members will be decisive in helping them achieve their clinical and commercial objectives” says Professor Lo, president of HKBMIA 

“We are delighted that HKBMIA has welcomed Cerba Research into their network and look forward to sharing our expertise with China market. Our collaboration with Prof Lo and HKBMIA builds on a decade of collaboration within China and reflects our continuing ambition to facilitate research and development in the region, as well as in supporting innovative Chinese biopharmaceutical customers to expand beyond their shores” adds Daniel Tanner, Chief Commercial Officer, Cerba Research. 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Cerba Research. (2023, April 11). Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA). News-Medical. Retrieved on February 27, 2024 from https://www.news-medical.net/news/20230106/Cerba-Research-is-officially-a-member-of-Hong-Kong-Bio-Med-Innotech-Association-(HKBMIA).aspx.

  • MLA

    Cerba Research. "Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA)". News-Medical. 27 February 2024. <https://www.news-medical.net/news/20230106/Cerba-Research-is-officially-a-member-of-Hong-Kong-Bio-Med-Innotech-Association-(HKBMIA).aspx>.

  • Chicago

    Cerba Research. "Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA)". News-Medical. https://www.news-medical.net/news/20230106/Cerba-Research-is-officially-a-member-of-Hong-Kong-Bio-Med-Innotech-Association-(HKBMIA).aspx. (accessed February 27, 2024).

  • Harvard

    Cerba Research. 2023. Cerba Research is officially a member of Hong Kong Bio-Med Innotech Association (HKBMIA). News-Medical, viewed 27 February 2024, https://www.news-medical.net/news/20230106/Cerba-Research-is-officially-a-member-of-Hong-Kong-Bio-Med-Innotech-Association-(HKBMIA).aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Cerba Healthcare to acquire Canadian contract research laboratory Cirion Biopharma Research to expand bioanalytical capabilities and shorten time-to-deploy complex clinical trials